Flu Antigen Tests Reclassified as Class II Devices

Effective this month, the U.S. Food and Drug Administration (FDA) has reclassified antigen-based, rapid influenza virus antigen detection test systems (RIDTs) used directly on clinical specimens from Class I to Class II devices. Further, the FDA is introducing special controls aimed at improving the overall quality of flu testing and reducing the number of misdiagnosed…